Skip to content

The effect of the Meniett in patients with unstable Meniere's disease

The effect of the Meniett in patients with unstable Meniere's disease - Meniett puls therapy in Menière's disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON31493
Enrollment
32
Registered
2008-03-25
Start date
2009-08-07
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dizziness spells Vertigo spells

Interventions

A tympanic tube will be inserted in all subject under lokal anesthesia. Two weeks after insertion of the tympanic tube treatment will start. After randomisation half of the patients will start the t

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: defenite Menière acoording to the AAO-HNS: two or more vertigo spells >20 minutes audiometrically documented hearing loss at at least one occasion Tinnitus or aural fullness in the treated ear Other auses excluded 2. Instable Menière*s disease: at least 3 vertigo spells en/or fluctuating hearing loss in the three months prior to inclusion

Exclusion criteria

Exclusion criteria: controlateral pathology of the ear ipsilateral pathology of the middle ear chirurgic treatment for Menière*s disease

Design outcomes

Primary

MeasureTime frame
frequency of the vertigo spells

Secondary

MeasureTime frame
duration of vertigo spells functionality level scale Dizziness Handicap Inventory Hearing thresholds

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)